Interviews

Why pharma services is such an attractive investment space

Last week Telemos Capital, a European mid-market private equity firm backed by family capital, bought Helios Global Group, a full-service global healthcare communications provider, from NorthEdge, a regional lower mid-market private equity company. We spoke with one of the deal's advisors — Tom Cowap, Managing Director at Baird, an employee-owned international investment bank — about how this is a bellwether for growing private equity interest in the med comms and wider pharma services space.

Healthcare providers and researchers can use software to get the most out of health records — an interview with Dexter

Dexter is a UK-based software company that provides a platform designed to get the most out of electronic healthcare records. The platform can be used to automate the process of running clinical trials based on ‘real world’ evidence from health record data, but it can also be used by healthcare providers to improve their operations (this part of the platform is called DexterCare). 

Interview: Phil Frame, NorthEdge

NorthEdge is a regionally focussed UK PE firm, headquartered in Manchester and with presence across the North and Midlands. It invests in lower mid-market companies across the healthcare, technology and business services sectors, and currently has £900m of assets under management.  In an interview with HBI, Phil Frame, Partner and Healthcare Investment Lead at NorthEdge, discussed some of the areas of healthcare innovation the firm is currently most excited about, and the abundant opportunity in the UK regions.

Interview: Dr Oliver Harrison, Koa Health

Dr Oliver Harrison is the founder and chief executive of Koa Health, a UK-headquartered digital mental health company. He spoke to us about what makes Koa Health different and about the company’s new employer-funded mental health platform which he describes as the culmination of the work the company has been doing to date.

Bioprinting could revolutionise medicine — an interview with Vidmantas Sakalys, CEO of Vital3D Technologies

Bioprinting is an innovative 3D printing technology that can create artificial organic structures such as tissues and organs. The technology has the potential to revolutionise healthcare because the ‘printed’ structures, despite being man-made, are composed of real living cells.

Remote patient monitoring can cut chronic disease care costs by 40% — an interview with Lasse Rousi, Medixine 

Over the coming years and decades an increasing amount of care will be delivered to patients in their homes. New devices and wearables that can collect health data from people whilst they’re at home and healthcare’s digitalisation trend are opening up new possibilities, both for prevention and for providing better and more efficient care to those with chronic conditions. 

Interview: Dom Longford, Cog ADHD

Cog ADHD is a digital platform for people with ADHD. The company officially launched its new app on iOS and Android earlier this month. Dom Longford, the company’s founder, explained to HBI how the platform's holistic approach to supporting people with ADHD can help fill the gaps left by failing public mental health systems.

Interview: Dr. Guillermo Moreno-Sanz, Zerenia Clinic

Zerenia Clinic is a UK-based private healthcare provider specialising in treatments with cannabis-based medicinal products (CBMP). Last year it attained the UK’s first ever NHS reimbursement for cannabis flowers. In an interview with HBI, Dr. Guillermo Moreno-Sanz, Scientific Director at Zerenia’s parent company, Khiron Europe (a pharma company producing CBMPs), spoke about the growing opportunity in Europe’s medicinal cannabis space.

Addressing healthcare workforce inefficiency through AI and 3d indoor mapping – a conversation with Connie Moser of Navenio

Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]

Investors eye wellness testing in veterinary medicine — Interview with Eve Hanks, CEO of MI:RNA Diagnostics

  The UK, Germany, and France lead in veterinary diagnostics, while southern Europe lags According to UK’s online pet marketplace Pets4Homes, demand for puppies for sale rose by 104% at the peak of the lockdown in May 2020. S&P Global notes animal diagnostics is now a growing area.  MI:RNA Diagnostics, a Scottish veterinary diagnostics company, […]

Find Us